Cargando…
Evaluating blinatumomab implementation in low- and middle-income countries: a study protocol
BACKGROUND: The recent implementation of novel therapies has accelerated progress in pediatric cancer care. Despite the significantly poorer survival of patients in low- and middle-income countries (LMICs), administation complexities and other significant resource barriers have limited the translati...
Autores principales: | Duffy, Caitlyn, Santana, Victor, Inaba, Hiroto, Jeha, Sima, Pauley, Jennifer, Sniderman, Liz, Ghara, Niharendu, Mushtaq, Naureen, Narula, Gaurav, Bhakta, Nickhill, Rodriguez-Galindo, Carlos, Brandt, Heather |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187890/ https://www.ncbi.nlm.nih.gov/pubmed/35690878 http://dx.doi.org/10.1186/s43058-022-00310-5 |
Ejemplares similares
-
Comparative treatment costs of risk‐stratified therapy for childhood acute lymphoblastic leukemia in India
por: Mungle, Tushar, et al.
Publicado: (2022) -
Global Access to Essential Medicines for Childhood Cancer: A Cross-Sectional Survey
por: Cohen, Phillip, et al.
Publicado: (2018) -
Factors influencing treatment decision‐making for cancer patients in low‐ and middle‐income countries: A scoping review
por: Salek, Marta, et al.
Publicado: (2023) -
Addressing the Gap in Research Methodologies Education in Pediatric Oncology in the Eastern Mediterranean Region
por: Saab, Raya, et al.
Publicado: (2023) -
Blinatumomab in pediatric patients with relapsed/refractory acute lymphoblastic leukemia: results of the RIALTO trial, an expanded access study
por: Locatelli, Franco, et al.
Publicado: (2020)